Patents by Inventor Eiji Sunami

Eiji Sunami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160115547
    Abstract: A method of detecting circulating DNA in a body fluid. The method comprises identifying a subject suffering from or at risk for developing cancer, obtaining a body fluid sample from the subject, and determining the sequence integrity of circulating DNA in the sample, wherein the circulating DNA is not purified from the sample.
    Type: Application
    Filed: June 26, 2015
    Publication date: April 28, 2016
    Inventors: Dave S.B. Hoon, Naoyuki Umetani, Eiji Sunami
  • Publication number: 20150240316
    Abstract: The invention relates to a method of detecting LINE-1 (long interspersed nucleotide elements-1) DNA either methylated or unmethylated at the promoter region in a tissue or body fluid sample from a subject. Also disclosed are methods of using LINE-1 DNA as a biomarker for diagnosing, predicting, and monitoring cancer progression and treatment.
    Type: Application
    Filed: October 2, 2014
    Publication date: August 27, 2015
    Inventors: Dave S.B. Hoon, Eiji Sunami
  • Publication number: 20110159501
    Abstract: The invention relates to a method of detecting LINE-1 (long interspersed nucleotide elements-1) DNA either methylated or unmethylated at the promoter region in a tissue or body fluid sample from a subject. Also disclosed are methods of using LINE-1 DNA as a biomarker for diagnosing, predicting, and monitoring cancer progression and treatment.
    Type: Application
    Filed: December 30, 2010
    Publication date: June 30, 2011
    Inventors: Dave S.B. Hoon, Eiji Sunami
  • Publication number: 20110159502
    Abstract: The invention relates to a method of detecting LINE-1 (long interspersed nucleotide elements-1) DNA either methylated or unmethylated at the promoter region in a tissue or body fluid sample from a subject. Also disclosed are methods of using LINE-1 DNA as a biomarker for diagnosing, predicting, and monitoring cancer progression and treatment.
    Type: Application
    Filed: December 30, 2010
    Publication date: June 30, 2011
    Inventors: Dave S.B. Hoon, Eiji Sunami
  • Publication number: 20110159510
    Abstract: The invention relates to a method of detecting LINE-1 (long interspersed nucleotide elements-1) DNA either methylated or unmethylated at the promoter region in a tissue or body fluid sample from a subject. Also disclosed are methods of using LINE-1 DNA as a biomarker for diagnosing, predicting, and monitoring cancer progression and treatment.
    Type: Application
    Filed: December 30, 2010
    Publication date: June 30, 2011
    Inventors: Dave S.B. Hoon, Eiji Sunami
  • Publication number: 20110151465
    Abstract: The invention relates to a method of detecting LINE-1 (long interspersed nucleotide elements-1) DNA either methylated or unmethylated at the promoter region in a tissue or body fluid sample from a subject. Also disclosed are methods of using LINE-1 DNA as a biomarker for diagnosing, predicting, and monitoring cancer progression and treatment.
    Type: Application
    Filed: December 30, 2010
    Publication date: June 23, 2011
    Inventors: Dave S.B. Hoon, Eiji Sunami
  • Publication number: 20090280479
    Abstract: A method of detecting circulating DNA in a body fluid. The method comprises identifying a subject suffering from or at risk for developing cancer, obtaining a body fluid sample from the subject, and determining the sequence integrity of circulating DNA in the sample, wherein the circulating DNA is not purified from the sample.
    Type: Application
    Filed: May 30, 2006
    Publication date: November 12, 2009
    Applicant: JOHN WAYNE CANCER INSTITUTE
    Inventors: Dave S.B. Hoon, Naoyuki Umetani, Eiji Sunami
  • Publication number: 20090068660
    Abstract: The invention relates to a method of detecting LINE-1 (long interspersed nucleotide elements-1) DNA either methylated or unmethylated at the promoter region in a tissue or body fluid sample from a subject. Also disclosed are methods of using LINE-1 DNA as a biomarker for diagnosing, predicting, and monitoring cancer progression and treatment.
    Type: Application
    Filed: April 25, 2008
    Publication date: March 12, 2009
    Applicant: JOHN WAYNE CANCER INSTITUTE
    Inventors: Dave S.B. Hoon, Eiji Sunami